Mandy Lauw: International Collaboration Provides New Evidence for Splanchnic Vein Thrombosis Care
Mandy Lauw, Internist-Hematologist at Erasmus MC, reposted from JTH on LinkedIn, about a recent article she and her colleagues co-authored, published in JTH, adding:
”Proud of this important publication on splanchnic vein thrombosis (SVT) by our PhD-student Amica Ko.
- Similar recurrence, bleeding and survival outcomes of SVT with MPN and without MPN
- Patients with MPN and SVT can likely be treated similarly to patients with non-cirrhosis, non-malignancy associated SVT
Work in close partnership with Italian colleagues Laura Milana, Nicoletta Riva and Walter Ageno.
And thanks to collaborators of the 3 included studies from across the world, among which Marc Carrier, Peter Verhamme, Laurent Bertoletti, Aurelien Delluc Pieter, Willem Kamphuisen, Alejandro Lazo Langner, Elvira Grandone, Alberto Tosetto, Frank Leebeek.”
Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post:
”Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study
Does a myeloproliferative neoplasm change the outlook after splanchnic vein thrombosis?
In this large cohort, rates of recurrent thrombosis, bleeding, and survival at six months were similar whether or not patients had an MPN.
The authors suggest MPN-related splanchnic vein thrombosis can be managed much like noncirrhotic, nonmalignant disease, while longer prospective follow-up is still needed.”
Title: Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study
Authors: Amica K. Ko, Laura Milana, Nicoletta Riva, Lorenza Bertu, Laurent Bertoletti, Jan Beyer-Westendorf, Marc Carrier, Aurelien Delluc, Elvira Grandone, Pieter Kamphuisen, Alejandro Lazo-Langner, Margherita Maffioli, Daniela Poli, Sam Schulman, Marco Senzolo, Sophie Testa, Alberto Tosetto, Peter Verhamme, Frank W.G. Leebeek, Sarwa Darwish Murad, Walter Ageno, Mandy N. Lauw

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session